9-136209044-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_181701.4(QSOX2):āc.1781T>Cā(p.Leu594Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_181701.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
QSOX2 | NM_181701.4 | c.1781T>C | p.Leu594Pro | missense_variant | 12/12 | ENST00000358701.10 | NP_859052.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
QSOX2 | ENST00000358701.10 | c.1781T>C | p.Leu594Pro | missense_variant | 12/12 | 2 | NM_181701.4 | ENSP00000351536.5 | ||
QSOX2 | ENST00000706609.1 | n.967T>C | non_coding_transcript_exon_variant | 6/6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251232Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135832
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461808Hom.: 0 Cov.: 34 AF XY: 0.00000825 AC XY: 6AN XY: 727180
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 05, 2022 | The c.1781T>C (p.L594P) alteration is located in exon 12 (coding exon 12) of the QSOX2 gene. This alteration results from a T to C substitution at nucleotide position 1781, causing the leucine (L) at amino acid position 594 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at